36 primary sources
Check our work.
Provider pages, manufacturer terms, FDA information and prescribing labels. Every listing links back to its evidence.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- CoreAge Rx — treatment catalog ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — product and plan terms ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — Compounded semaglutide ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — Compounded tirzepatide ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — Sermorelin ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — NAD+ injection ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — NAD+ nasal ↗
Official public information; price and terms checked October 8, 2026.
- CoreAge Rx — Bounce Back ↗
Official public information; price and terms checked October 8, 2026.
- OrderlyMeds — full pricing ↗
Official public information; price and terms checked October 8, 2026.
- Mochi Health — pricing FAQ ↗
Official public information; price and terms checked October 8, 2026.
- Henry Meds — program pricing and commitments ↗
Official public information; price and terms checked October 8, 2026.
- Henry Meds — advertised weight management plans ↗
Official public information; price and terms checked October 8, 2026.
- Ro — membership and medication prices ↗
Official public information; price and terms checked October 8, 2026.
- AgelessRx — Sermorelin ↗
Official public information; price and terms checked October 8, 2026.
- AgelessRx — NAD+ injection ↗
Official public information; price and terms checked October 8, 2026.
- AgelessRx — Glutathione injection ↗
Official public information; price and terms checked October 8, 2026.
- AgelessRx — Glutathione nasal spray ↗
Official public information; price and terms checked October 8, 2026.
- AgelessRx — glutathione introductory and recurring prices ↗
Official public information; price and terms checked October 8, 2026.
- Strut Health — sermorelin pricing ↗
Official public information; price and terms checked October 8, 2026.
- Strut Health — wellness catalog ↗
Official public information; price and terms checked October 8, 2026.
- FDA — Strut Health warning letter, February 20, 2026 ↗
Published letter about compounded GLP-1 marketing; subsequent regulatory status is not established by this review.
- Eden — NAD+ plans and inclusions ↗
Official public information; price and terms checked October 8, 2026.
- Ivím — individualized GLP-1 program ↗
Official public information; price and terms checked October 8, 2026.
- Lilly — Zepbound self-pay and savings terms ↗
Official public information; price and terms checked October 8, 2026.
- Lilly — Foundayo self-pay and savings terms ↗
Official public information; price and terms checked October 8, 2026.
- NovoCare — Wegovy pricing by formulation ↗
Official public information; price and terms checked October 8, 2026.
- The Ordinary — Multi-Peptide + Copper Peptides 1% ↗
Official public information; price and terms checked October 8, 2026.
- NIOD — Copper Amino Isolate Lipid 1% ↗
Official public information; price and terms checked October 8, 2026.
- Vyleesi — access, eligibility and safety ↗
Official public information; price and terms checked October 8, 2026.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
- FDA — concerns with unapproved GLP-1 drugs ↗
Safety, dosing errors, salt forms and misleading online marketing.
- FDA — ingredients for sterile compounding ↗
NAD+ adverse-event reports and ingredient-quality concerns; not a finding about any listed provider.
- FDA — compounding substances with potential safety risks ↗
Includes injectable GHK-Cu; route-specific concerns must not be applied indiscriminately to cosmetics.
- FDA — Foundayo approval, April 1, 2026 ↗
Approval and indicated population; a non-peptide GLP-1 medicine.
- Wegovy — prescribing information ↗
Formulation-specific approved uses, contraindications and warnings.
- Zepbound — prescribing information ↗
Approved uses, contraindications and warnings.